Systematic Hereditary Pancreatic Cancer Risk Assessment and Implications for Personalized Therapy

NCT03060720 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
271
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Dana-Farber Cancer Institute

Collaborators